Series A funding helps company develop innovative therapies in oncology, metabolic and renal diseases
The Italian space company will launch two of its orbital transfer vehicles with satellites from different customers in 2025.
Click here to read previous Newsletters
Subscribe to the newsletter
yes
en
* I agree that my personal data will be used in accordance with the Privacy and Cookie Policy.
* I authorize the processing of my personal data to be updated on new arrivals and for direct marketing purposes related to the services offered.